Vulnerability in Mirion Biodose\/nmis
CVE-2025-61940
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 8.3 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L.
EPSS exploit prediction
EPSS: 0.003 (23.9th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 24th percentile — 23.9% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.003 · newest: 0.003 · change: 0.000
Affected products
- Mirion Biodose\/nmis
- Mirion Medical Ec2 Software Nmis Biodose — versions 0, 23.0
Weakness classification (CWE)
References
- www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01 (Third Party Advisory)
Frequently asked questions
- What is CVE-2025-61940?
- CVE-2025-61940 is a high-severity vulnerability in Mirion Biodose\/nmis, classified under CWE-603. CVSS score: 8.3/10. Published 2025-12-02.
- How severe is CVE-2025-61940?
- High severity. CVSS v3 base score is 8.3 out of 10.